Search results :

Olsalazine

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: A07EC03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Cramp muscle 10.1% 7.2% x x
Diarrhoea 5.9% 4.81% x x x
Loose stools 5.9% 4.81% x x
Abdominal pain 1.13% - 10.1% 0% - 7.2% x x
Arthralgia 4% 2.9% x x x
Dyspepsia 4% 4.3% x x x
Headache 3% - 5% 0% - 4.8% x x x
Nausea 3% - 5% 2% - 3.9% x x x
Heartburn 2% 0% x x
Drowsiness 1.8% 2.9% x x
Fatigue 1.8% 2.9% x x
Lethargy 1.8% 2.9% x x
Rash 1.13% - 2.3% 0% - 1.4% x x x
Upper respiratory tract infection 1.5% x x
Abdominal bloating 1.5% 1.4% x x
Depression 1% - 1.5% 0% x x
Pruritus 1.13% - 1.3% 0% x x x
Anorexia 1% - 1.3% 0% - 1.9% x x
Dizziness 1% 0% x x x
Stomatitis 1% x x
Vertigo 1% x x
Vomiting 1% x x x
Lightheadedness 1% 0% x x
Rectal haemorrhage 1% 0% x x
Insomnia 1% 0% - 2.4% x x
Aplastic anaemia postmarketing x x x
Angioedema postmarketing x x x
Connective tissue disorder postmarketing x x x
Dyspnoea postmarketing x x x
Body temperature increased postmarketing x x x
Hepatitis postmarketing x x x
Jaundice postmarketing x x
Jaundice cholestatic postmarketing x x
Mediastinal disorder postmarketing x x x
Nephritis interstitial postmarketing x x x
Nervous system disorder postmarketing x x x
Pancytopenia postmarketing x x x
Paraesthesia postmarketing x x x
Neuropathy peripheral postmarketing x x
Urinary tract disorder postmarketing x x x
Hepatic failure postmarketing x x
Hepatocellular injury postmarketing x x
Hepatic necrosis postmarketing x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x
Interstitial lung disease postmarketing x x x
Myalgia postmarketing x x x
Hepatotoxicity postmarketing x x
Hepatic enzyme increased postmarketing x x x
Hepatobiliary disease postmarketing x x x
Blood bilirubin increased postmarketing x x x
Blood and lymphatic system disorders postmarketing x x x
Raised liver function tests postmarketing x x
Alopecia x x x
Anaemia x x x
Haemolytic anaemia x x
Mental disorder x x x
Breast disorder x x
Bronchospasm x x
Chest pain x x
Infection x x
Dehydration x x
Dysuria x x
Eosinophilia x x x
Erythema nodosum x x
Eye disorder x x x
Flatulence x x
Gastrointestinal disorder x x x
Cardiac disorder x x x
Haematuria x x
Hypertension x x
Orthostatic hypotension x x
Immune system disorder x x
Irritability x x
Leukopenia x x x
Lung disorder x x
Lymphopenia x x
Menorrhagia x x
Myocarditis x x x
Nephrotic syndrome x x
Neutropenia x x x
Palpitations x x x
Pancreatitis x x x
Pericarditis x x x
Proteinuria x x
Tachycardia x x x
Thrombocytopenia x x x
Thyroid disorder x x
Tinnitus x x
Tremor x x
Erythema x x
Pollakiuria x x
Urticaria x
Angiopathy x x
Dry mouth x x
Fever chills x x
Mood swings x x
Oedema peripheral x x
Hepatitis cholestatic x x
Malnutrition x x
Photosensitivity reaction x x x
Reticulocytosis x x
Abdominal pain upper x
Hepatitis granulomatous x x
Erectile dysfunction x x
Atrioventricular block second degree x x
Dry eye x x
Vision blurred x x x
Rigors x x
Discomfort rectal x x
Hot flush x x
Infestation NOS x x
Ear and labyrinth disorders x x
Epigastric discomfort x x
Death x x
Blood in stool 3.4% x x
Tearing eyes x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

DIPENTUM / Dipentum, Tablet

Side effects:48
Source:Medsafe

olsalazine

Side effects:113
Source:FDA Structured Product Label

olsalazine

Side effects:114
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label